Biogen Inc (NASDAQ:BIIB) - Share price - Overview

Stock Report

Biogen Inc BIIB

Last Price
$286.90

Day Change
-2.04|-0.71%

As of 21/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close288.94
Day Range286.22 - 289.91
Mkt Cap61.96Bil
52-Wk Range205.43 - 307.33
Yield %-
ISINUS09062X1037
Volume1,471,212
P/E16.95
P/S5.48
P/CF13.88

Share Price

Financials
201420152016
More ...
Income Statement
Revenue9,703.3210,763.8011,448.80
Operating Income3,955.664,891.005,150.40
Net Income2,934.783,547.003,702.80
Basic EPS12.4215.3816.96
Avg. Diluted Shares Outstanding237231219
Balance Sheet
Current Assets4,672.676,700.308,732.20
Non Current Assets9,643.8912,804.5014,144.60
Total Assets14,316.5619,504.8022,876.80
Current Liabilities2,219.712,577.703,419.90
Total Liabilities3,507.5510,132.0010,736.70
Total Equity10,809.019,372.8012,140.10
Cash Flow
Operating Cash Flow2,942.123,716.104,522.40
Capital Expenditure-287.75-643.00-727.70
Free Cash Flow2,654.363,073.103,794.70

In millions, except "Basic EPS". Currency is USD.

Company Profile

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

7,400
Key Stats
More ...
Price/Earning TTM17.04
Price/Book5.14
Price/Sales TTM5.56
Rev Growth (3 year avg)18.20
EPS Growth (3 year avg)-
Operating Margin % TTM44.99
Net Margin % TTM32.34
ROE TTM34.42
Debt/Equity0.54
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.